Webinar on

HIV/AIDS

November 23, 2020

hiv-aids-2020

Theme: Enhance competency in HIV Prevention and Care

Webinar on HIV/AIDS, with members from around the world focused on learning about HIV/AIDS & STDs/STIs, this is your single best opportunity to reach the largest assemblage of participants from the hospitals, Universities, community. The field of HIV/AIDS is developing quickly and its improvement is making tremendous effects on therapeutic sciences and pharmaceuticals. HIV webinar will conduct demonstrations, distribute information, meet with current and potential researchers and receive name recognition event. World-renowned doctors, researchers, scientists, speakers, the most recent techniques, tactics, and the newest updates in respective field are hallmarks of this HIV-online conference. This HIV webinar will offer an exciting scientific program, composed of state-of-the-art plenary lectures and abstract-driven sessions presenting the latest research in the field of HIV medicine. 

Session 1: HIV/AIDS and Retroviral Diseases
 
36.7 million People were living with HIV in 2016; it was 33.2 million in 2010, the result of continuing new infections, people living longer with HIV, and general population growth. Global prevalence has leveled since 2001 and was 0.8% in 2016.Despite these challenges, new global efforts have been mounted to address the epidemic and there has been significant progress. This HIV online conference will also include the topic of Retroviruses diseases. Retroviruses induce diseases that do not fit easily into any of the major categories and different tissues can influence the type of disease that develops the first retrovirus associated with disease was equine infectious anemia virus (EIAV).  BFU-E and CFU-E   contained by anemic cats is very less, and FeLV infection suppresses the generation of these precursors in vitro. While murine retroviruses are inactivated by human complement and are not capable of causing human disease.
 
Session 2: HIV Related Infections, Cancers
 
There are a number of people living with HIV, infections and cancers. In HIV 2019 Conference we will endeavor to talk about continuous research of this theme. HIV, co-infections and cancers are Hepatitis B, hepatitis C, tuberculosis, sexually transmitted infections (STIs), human papillomavirus (HPV) and herpes, and fungal infections, Hodgkin’s lymphoma, lung cancer, skin cancer, anal cancer, cervical and vaginal cancer in women, and testicular and prostate cancer in men. These growths can frequently be effectively treated on the off chance that they happen in individuals with HIV who keep up solid safe frameworks with HIV treatment.
 
Session 3: HIV Drug Discovery, Research & Vaccines
 
After the virus was discovered 25 years ago the development of drugs for HIV infection began. Since then, progress has been substantial, but numerous uncertainties persist about the best way to manage this disease. With a view to the next quarter century, we consider whether drug resistance can be avoided, which drug classes will be favored over others, which strategies are most likely to succeed, and the potential impact of pharmacogenomics and individualized therapy. Vaccines have been one of best weapon against the infectious diseases. Vaccines are the more important for public health and an AIDS vaccine would play a powerful role in ensuring the end to the AIDS epidemic.
 
Session 4: Viral, Bacterial, Fungal & Protozoan STDs
 
STDs can be spread with sexual activity, depending on the disease. STDs are most obtained by viruses and bacteria. Bacterial and Viral STDs are obtained by viruses; this is the main difference between these two categories of (STDs). As a result of being caused by different microorganisms, bacterial and viral STDs vary in their treatment. In addition to bacteria and viruses, STDs can also be caused by protozoa (trichomoniasis) and other organisms (crabs/pubic lice and scabies). These STDs can be cured by antibiotics or topical creams/lotions. STDs need to be diagnosed correctly and fully treated as soon as possible to avoid complications that could be serious and/or permanent.
 
Session 5: Recent Advancement in Techniques involved in HIV/AIDS, STDs and STIs
 
The search for a preventive immunization that can stop the worldwide pandemic is a definitive objective of HIV research. Improvement of an immunization against HIV-1 has been tormented by numerous outlandish difficulties. Distinctive immunization ideas have been tried to conquer these difficulties. Trial immunizations that indicated guarantee in preclinical trials were progressed into clinical trials. However, human trials turned out to be an enormous dissatisfaction until the aftereffects of the RV144 trial in Thailand. Urine tests can be used to test for urethritis in both sexual orientations. Late urination will have washed gonorrheal discharge from the urethra. In this way, to accumulate sufficient discharge, pee tests should be taken no not as much as an hour after the patient's last pee. Vaginal swab illustrations are used to test for cervicitis. Gonorrheal cervicitis produces a satisfactory discharge that swabs require not be taken by speculum examination. Or maybe, they can be assembled unpredictably by the patient herself.

 

  • HIV/AIDS and Retroviral Diseases
  • HIV Related Infections, Cancers
  • HIV Drug Discovery, Research & Vaccines
  • Viral, Bacterial, Fungal & Protozoan STDs
  • Recent Advancement in Techniques involved in HIV/AIDS, STDs and STIs